Jushi Holdings Director Receives Grant of 100,000 Stock Options
Jushi Holdings Inc.
Subscribe to track JUSHF
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Jushi Holdings Director Receives Grant of 100,000 Stock Options
Company: Jushi Holdings Inc. (JUSHF) Form: 4 | Filed: 2025-12-15 Significance: Low
Insider: Cross Benjamin Title: Director Relationship: Director
Transaction: • Type: Grant (Stock Options) • Shares: 100,000 • Price: $0.00 • Value: $0 • Owned After: 100,000 options
Key Insight: A director was awarded 100,000 stock options with an exercise price of $0.50 as part of a standard compensation package to align insider and shareholder interests.
Market Context: This is a non-cash equity grant, not an open-market transaction. The options vest over a three-year period, contingent on continued service.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Jushi Holdings Inc. (JUSHF)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine compensatory grant of 100,000 stock options.
- Market Impact: Neutral. This is a standard corporate action to align director and shareholder interests, not an open-market trade reflecting new investment sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Jushi Holdings Inc. |
| Ticker Symbol | JUSHF |
| CIK | 0001909747 |
| Industry | Medicinal Chemicals & Botanical Products |
Insider Information
| Field | Value |
|---|---|
| Name | Cross Benjamin |
| CIK | 0001939735 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-11 |
| Transaction Code | A (Grant) |
| Security Type | Stock Option (right to buy) |
| Shares Involved | 100,000 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 100,000 (options) |
| Ownership Type | Direct |
Financial Impact Assessment
Impact Evaluation
- Valuation Context: The transaction is a grant with a reported value of $0. The options have an exercise price of $0.50 and a 10-year expiration date, giving them potential future value if the underlying stock price appreciates.
- Dilution Impact: This grant represents a potential future dilution of 100,000 shares upon exercise. As market data for total shares outstanding was not available, the precise dilutive percentage cannot be calculated, but such grants are a common component of executive and director compensation.
- Transaction Significance: The significance is considered low as it is a non-cash, compensatory award rather than an open-market transaction funded by the insider's own capital.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Compensatory stock option grants are routine and do not typically influence short-term price action. They are forward-looking incentives, not indicators of an insider's current market thesis.
Volume & Sentiment
- Expected Volume Impact: None. The transaction did not occur on the open market.
- Sentiment Indicator: Neutral. The filing is informational and aligns with standard corporate governance practices.
Additional Context
Transaction Notes
- Vesting Schedule: The options are subject to a three-year vesting schedule. 1/3 will vest on December 11, 2026, 1/3 on December 11, 2027, and the final 1/3 on December 11, 2028, contingent on the director's continuous service.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.